These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
898 related items for PubMed ID: 12778055
1. Development of potent monoclonal antibody auristatin conjugates for cancer therapy. Doronina SO, Toki BE, Torgov MY, Mendelsohn BA, Cerveny CG, Chace DF, DeBlanc RL, Gearing RP, Bovee TD, Siegall CB, Francisco JA, Wahl AF, Meyer DL, Senter PD. Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055 [Abstract] [Full Text] [Related]
2. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Doronina SO, Mendelsohn BA, Bovee TD, Cerveny CG, Alley SC, Meyer DL, Oflazoglu E, Toki BE, Sanderson RJ, Zabinski RF, Wahl AF, Senter PD. Bioconjug Chem; 2006 Jul; 17(1):114-24. PubMed ID: 16417259 [Abstract] [Full Text] [Related]
3. In vivo drug-linker stability of an anti-CD30 dipeptide-linked auristatin immunoconjugate. Sanderson RJ, Hering MA, James SF, Sun MM, Doronina SO, Siadak AW, Senter PD, Wahl AF. Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):843-52. PubMed ID: 15701875 [Abstract] [Full Text] [Related]
4. Secondary mAb--vcMMAE conjugates are highly sensitive reporters of antibody internalization via the lysosome pathway. Klussman K, Mixan BJ, Cerveny CG, Meyer DL, Senter PD, Wahl AF. Bioconjug Chem; 2004 Jan 15; 15(4):765-73. PubMed ID: 15264863 [Abstract] [Full Text] [Related]
5. Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate. Hamblett KJ, Senter PD, Chace DF, Sun MM, Lenox J, Cerveny CG, Kissler KM, Bernhardt SX, Kopcha AK, Zabinski RF, Meyer DL, Francisco JA. Clin Cancer Res; 2004 Oct 15; 10(20):7063-70. PubMed ID: 15501986 [Abstract] [Full Text] [Related]